captopril has been researched along with pentoxifylline in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 8 (38.10) | 29.6817 |
| 2010's | 8 (38.10) | 24.3611 |
| 2020's | 3 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Haustein, UF | 1 |
| Fartasch, M; Kirchner, T; Mahler, V; Neureiter, D; Schuler, G | 1 |
| Bakowski, D; Brzyźkiewicz, H; Janion, M | 1 |
| Amini, M; Aminian, T; Aminorroaya, A; Gharavi, M; Janghorbani, M; Rezvanian, H | 1 |
| Guerrero-Romero, F; Rodríguez-Morán, M | 1 |
| Akbari, A; Doucette, S; Fergusson, D; Knoll, G; McCormick, BB; Sydor, A | 1 |
| Afshariani, R; Banihashemi, MA; Ghezlou, M; Moini, M; Roozbeh, J; Sagheb, MM; Salari, S | 1 |
| Abdollahifar, MA; Jahanabadi, Z; Noorafshan, A; Shirazi, M; Soltani, MR; Tanideh, N | 1 |
| Aliev, OI; Anishchenko, AM; Arkhipov, AM; Plotnikov, MB; Shamanaev, AY; Sidekhmenova, AV | 1 |
| Beltz, TG; Felder, RB; Guo, F; Johnson, AK; Wei, SG; Xue, B; Yu, Y | 1 |
| Entezari-Maleki, T; Khani, E; Namdar, H; Pourrashid, MH | 1 |
| Fang, ZQ; Huo, YL; Johnson, AK; Li, JD; Peng, W; Wang, HP; Wang, XF; Xue, B; Zhang, YP | 1 |
3 review(s) available for captopril and pentoxifylline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Current status and trends in treatment of scleroderma].
Topics: Captopril; Combined Modality Therapy; Dextrans; Epoprostenol; Humans; Immunosuppressive Agents; Nifedipine; Pentoxifylline; Scleroderma, Systemic | 1992 |
The effect of pentoxifylline on proteinuria in diabetic kidney disease: a meta-analysis.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Diabetic Nephropathies; Humans; Kidney; Pentoxifylline; Phosphodiesterase Inhibitors; Proteinuria | 2008 |
4 trial(s) available for captopril and pentoxifylline
| Article | Year |
|---|---|
Comparison of the effect of pentoxifylline and captopril on proteinuria in patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Captopril; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Male; Middle Aged; Pentoxifylline; Proteinuria | 2005 |
Pentoxifylline is as effective as captopril in the reduction of microalbuminuria in non-hypertensive type 2 diabetic patients--a randomized, equivalent trial.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chi-Square Distribution; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Pentoxifylline; Statistics, Nonparametric; Treatment Outcome | 2005 |
Captopril and combination therapy of captopril and pentoxifylline in reducing proteinuria in diabetic nephropathy.
Topics: Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chi-Square Distribution; Diabetic Nephropathies; Drug Therapy, Combination; Female; Free Radical Scavengers; Humans; Male; Middle Aged; Pentoxifylline; Proteinuria; Regression Analysis; Treatment Outcome | 2010 |
Effects of Adding Pentoxifylline to Captopril on Primary Hypertension: A Pilot Randomized Clinical Trial.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Drug Synergism; Drug Therapy, Combination; Essential Hypertension; Female; Humans; Male; Middle Aged; Pentoxifylline; Pilot Projects; Platelet Aggregation Inhibitors; Single-Blind Method | 2020 |
14 other study(ies) available for captopril and pentoxifylline
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
[Digital ischemia as paraneoplastic marker of metastatic endometrial carcinoma].
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Captopril; Cystadenocarcinoma, Papillary; Diagnosis, Differential; Endometrial Neoplasms; Female; Fingers; Gangrene; Humans; Ischemia; Paraneoplastic Syndromes; Pentoxifylline; Uterine Neoplasms | 1999 |
[Disturbances of rhythm and atrio-ventricular conduction in digitalis overdose. Case reports].
Topics: Aged; Aged, 80 and over; Arrhythmias, Cardiac; Atrioventricular Node; Captopril; Digitalis; Digitalis Glycosides; Drug Interactions; Drug Overdose; Drug Therapy, Combination; Female; Heart Conduction System; Humans; Male; Medigoxin; Middle Aged; Pentoxifylline; Plants, Medicinal; Plants, Toxic; Tachycardia, Supraventricular | 2001 |
Stereological comparison of the effects of pentoxifylline, captopril, simvastatin, and tamoxifen on kidney and bladder structure after partial urethral obstruction in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Disease Models, Animal; Estrogen Antagonists; Free Radical Scavengers; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Male; Pentoxifylline; Rats; Simvastatin; Tamoxifen; Urethral Obstruction; Urinary Bladder Neck Obstruction | 2014 |
Pentoxifylline treatment enhances antihypertensive activity of captopril through hemorheological improvement in spontaneously hypertensive rats during development of arterial hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Blood Viscosity; Captopril; Cardiac Output; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Erythrocytes; Humans; Hypertension; Pentoxifylline; Platelet Aggregation Inhibitors; Rats; Rats, Inbred SHR; Vascular Resistance | 2017 |
Stress-Induced Sensitization of Angiotensin II Hypertension Is Reversed by Blockade of Angiotensin-Converting Enzyme or Tumor Necrosis Factor-α.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Brain; Captopril; Cytokines; Disease Models, Animal; Hypertension; Inflammation Mediators; Male; Microglia; Pentoxifylline; Rats, Long-Evans; Rats, Sprague-Dawley; Renin-Angiotensin System; Stress Disorders, Post-Traumatic; Tumor Necrosis Factor Inhibitors | 2019 |
Blockade of angiotensin-converting enzyme or tumor necrosis factor-α reverses maternal high-fat diet-induced sensitization of angiotensin II hypertension in male rat offspring.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animal Nutritional Physiological Phenomena; Animals; Antihypertensive Agents; Blood Pressure; Brain; Captopril; Diet, High-Fat; Disease Models, Animal; Female; Hypertension; Male; Maternal Nutritional Physiological Phenomena; Pentoxifylline; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Sprague-Dawley; Renin-Angiotensin System; Tumor Necrosis Factor Inhibitors | 2020 |